Fidelity's passive 10.4% stake is a routine update. Monitor for any conversion to a 13D (activist filing) or for significant changes in the stake size in future amendments.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5- T+0 · Nov 6 $49.02entry
- T+1 · 8d ago −12.67%α −15.03% · $42.81
- T+5 · 4d ago −16.65%α −19.24% · $40.86
- T+6 · todayOpen
- T+20 · in 20d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
FMR LLC (Fidelity) filed an amended Schedule 13G disclosing beneficial ownership of 4,871,850 shares of Hemab Therapeutics (COAG), representing 10.4% of outstanding common stock as of October 30, 2026. This is a routine passive stake update; no prior FMR 13G is in the provided context for comparison, so the direction of change is unknown.
Key Financial Metrics
Key Facts
- FMR LLC (Fidelity) filed an amended Schedule 13G for Hemab Therapeutics Holdings, Inc. (COAG).
- Beneficial ownership: 4,871,850 shares of common stock, representing 10.4% of outstanding shares as of October 30, 2026.
- Fidelity Management & Research Company LLC is the entity that beneficially owns 5% or greater of the outstanding shares.
- The filing is a passive investment disclosure under Rule 13d-1(b); FMR certifies the shares were not acquired to change or influence control.
- No prior FMR 13G for COAG was provided in the context, so the change in stake size cannot be determined.
Financial Impact
FMR LLC holds 4,871,850 shares (10.4% of COAG). At a $2.1B market cap, the stake is valued at approximately $218M.
Risk Factors
- No prior FMR 13G was provided; the direction of change (increase, decrease, or unchanged) is unknown.
- Passive 13G filings are routine and typically do not signal a change in investment thesis.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0000315066-26-002938 |
| Document: 0000315066-26-002938-index-headers.html | 0000315066-26-002938 |
| Document: 0000315066-26-002938-index.html | 0000315066-26-002938 |
| Document: 0000315066-26-002938.txt | 0000315066-26-002938 |
Track record
19 reports on COAG
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 10, 20266d ago Press Release Neutral 4/10 Entry $38.77 Now $39.06 +0.75% settles Nov 17
- Nov 9, 20267d ago Press Release Bullish 6/10 Entry $42.81 to $39.06 Now $39.06 −8.76% ▼ −8.77% −7.08% vs SPY
- Nov 6, 202610d ago SC 13G/A Neutral 3/10 Viewing Entry $49.02 to $40.86 Now $39.06 −20.32% ▼ −16.65% −19.24% vs SPY
- Nov 4, 202612d ago Press Release Neutral 4/10 Entry $45.09 to $39.33 Now $39.06 −13.37% ▼ −12.77% −11.86% vs SPY
- Sep 25, 20267w ago 3 Neutral 2/10 Entry $33.12 to $30.59 Now $39.06 +17.93% ▼ −7.64% −8.84% vs SPY
- Sep 17, 20268w ago Press Release Neutral 4/10 Entry $41.22 to $35.72 Now $39.06 −5.24% ▼ −13.34% −14.19% vs SPY
- Aug 11, 202613w ago 8-K Bullish 7/10 Entry $49.87 to $52.44 Now $39.06 −21.68% ▲ +5.15% +5.56% vs SPY
- Jun 17, 202621w ago Insider Buy Neutral 2/10 Entry $29.24 to $27.72 Now $39.06 +33.58% ▼ −5.20% −3.53% vs SPY
- May 21, 202625w ago Press Release Neutral 5/10 Entry $26.30 to $28.50 Now $39.06 +48.52% ▲ +8.37% +6.52% vs SPY
- May 4, 202628w ago 8-K Neutral 4/10 Entry $25.00 to $25.90 Now $39.06 +56.24% ▲ +3.60% +1.62% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers